Search

Your search keyword '"Jordi Stira"' showing total 26 results

Search Constraints

Start Over You searched for: Author "Jordi Stira" Remove constraint Author: "Jordi Stira"
26 results on '"Jordi Stira"'

Search Results

6. 85 - Major Adverse Cardiovascular Events (MACE) related to phosphodiesterase 5 inhibitors (PDE5I): Analysis of real-life data from Eudra-Vigilance (EV) database

7. 39 - Medications mostly associated with urinary tract infections (UTIs): Assessment of the EudraVigilance (EV) and Food and Drug Administration (FDA) pharmacovigilance databases entries

8. 38 - Prostate shape and intravesical prostatic protrusion assessed by magnetic resonance imaging are related to urinary symptoms

9. 35 - Post-voided residual urine ratio is a predictor of bladder outlet obstruction in men with lower urinary tract symptoms: Development of a clinical nomogram

10. 46 - Medications mostly associated with urinary retention: Assessment of the EudraVigilance (EV) and the Food and Drug Administration (FDA) pharmacovigilance database entries

11. 37 - Assessment of Bladder Wall Thickness (DWT) on multiparametric MRI depends on bladder volume

12. 36 - Sexual and functional outcomes after trans-urethral incision of the prostate: A long term follow up analysis

13. 45 - Post-voided residual urine ratio is a predictor of detrusor underactivity in men with lower urinary tract symptoms: Development of a clinical nomogram

14. MP24-13 PROSTATE SHAPE AND INTRAVESICAL PROSTATIC PROTRUSION ASSESSED BY MAGNETIC RESONANCE IMAGING ARE RELATED TO URINARY SYMPTOMS

15. MP34-14 MEDICATIONS MOSTLY ASSOCIATED WITH URINARY TRACT INFECTIONS (UTIS): ASSESSMENT OF THE EUDRAVIGILANCE (EV) AND FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASES ENTRIES

16. Ureteral stent encrustation: evaluation of available scores as predictors of a complex surgery

17. Serum levels of chromogranin are not predictive of poorly differentiated prostate cancer: Results from a multicenter radical prostatectomy cohort

18. MP48-06 ADVERSE EVENTS RELATED TO DAROLUTAMIDE TREATMENT: ANALYSIS OF 'REAL LIFE' DATA FROM EUDRAVIGILANCE (EV) AND THE FOOD AND DRUG ADMINISTRATION (FDA) DATABASE ENTRIES

19. PD38-03 ROLE OF POST-VOIDED RESIDUAL RATIO IN PATIENTS WITH DETRUSOR UNDERACTIVITY: A PRESSURE-FLOW STUDY ANALYSIS

20. PD39-03 POST-VOIDED RESIDUAL URINE RATIO IS A PREDICTOR OF BLADDER OUTLET OBSTRUCTION IN MEN WITH LOWER URINARY TRACT SYMPTOMS: DEVELOPMENT OF A CLINICAL NOMOGRAM

22. MP58-01 IS MRI AND FUSION BIOPSIES NECESSARY IN PATIENTS WITH PSA LEVELS >10 NG/ML?

23. MP19-09 OPEN ACCESS JOURNALS HAVE HIGHER METRICS THAN NON-OPEN ACCESS JOURNALS: ANALYSIS OF EUROPEAN UROLOGY AND JOURNAL OF UROLOGY METRICS

24. MP07-13 MEDICATIONS MOSTLY ASSOCIATED WITH HAEMATURIA: ASSESSMENT OF THE EUDRAVIGILANCE (EV) AND FOOD AND DRUG ADMINISTRATION (FDA) PHARMACOVIGILANCE DATABASES ENTRIES

26. Ureteral wall thickness and distal ureteral density in patients with residual fragments after Ho:YAG laser semi-rigid ureterolithotripsy

Catalog

Books, media, physical & digital resources